Long-Term Outcome of WHIM Syndrome in 18 Patients: High Risk of Lung Disease and HPV-Related Malignancies-Reference-Cited by-同舟云学术

Long-Term Outcome of WHIM Syndrome in 18 Patients: High Risk of Lung Disease and HPV-Related Malignancies

Published:2019-05 Issue:5 Volume:7 Page:1568-1577
ISSN:2213-2198
Container-title:The Journal of Allergy and Clinical Immunology: In Practice
language:en
Short-container-title:The Journal of Allergy and Clinical Immunology: In Practice

Author:

Dotta Laura,Notarangelo Lucia Dora,Moratto Daniele,Kumar Rajesh,Porta Fulvio,Soresina Annarosa,Lougaris Vassilios,Plebani Alessandro,Smith C. I. Edvard,Norlin Anna-Carin,Gòmez Raccio Andrea Cecilia,Bubanska Eva,Bertolini Patrizia,Amendola Giovanni,Visentini Marcella,Fiorilli Massimo,Venuti Aldo,Badolato Raffaele

Funder

Ministry of Health

Publisher

Elsevier BV

Subject

Immunology and Allergy

Reference42 articles.

1. “Myelokathexis”—a new form of chronic granulocytopenia. Report of a case;Zuelzer;N Engl J Med,1964

2. A new familial immunodeficiency disorder characterized by severe neutropenia, a defective marrow release mechanism, and hypogammaglobulinemia;Wetzler;Am J Med,1990

3. Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease;Hernandez;Nat Genet,2003

4. Recurrent CXCR4 sequence variation in a girl with WHIM syndrome;Alapi;Eur J Haematol,2007

5. Stromal-derived factor-1 abolishes constitutive apoptosis of WHIM syndrome neutrophils harbouring a truncating CXCR4 mutation;Sanmun;Br J Haematol,2006

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Increased Susceptibility of WHIM Mice to Papillomavirus-induced Disease is Dependent upon Immune Cell Dysfunction;PLOS Pathogens;2024-09-03

2. Expanding CXCR4 variant landscape in WHIM syndrome: integrating clinical and functional data for variant interpretation;Frontiers in Immunology;2024-07-08

3. The complex nature of CXCR4 mutations in WHIM syndrome;Frontiers in Immunology;2024-07-05

4. Mavorixafor: a new hope for WHIM syndrome;Blood;2024-07-04

5. A phase 3 randomized trial of mavorixafor, a CXCR4 antagonist, for WHIM syndrome;Blood;2024-07-04